Glide Pharmaceutical Technologies Ltd - Unquoted

Glide Pharma has developed a needle-free drug delivery technology known as Glide that is able to deliver a drug formulation in a solid, semi-liquid form directly through the skin of a patient. The Glide technology has been shown to have a number of benefits when compared to other delivery mechanisms. In trials on human volunteers, Glide's device was shown to be preferable to injection using a standard needle and syringe.


Glide Pharma

Last Updated: 24/07/2018

Investment Information:
date of first inv: Nov 2005
cost: £326,000
valn at: 30/06/2018 £nil
equity held: 1.2%